Vinay Sharma | Neurochemistry | Emerging Neuroscientist Award

Published on by Neuroscientists

Dr. Vinay Sharma | Neurochemistry | Emerging Neuroscientist Award

Dr. Vinay Sharma | Parul University | India

Dr. Vinay S. Sharma is an Assistant Professor in the Department of Chemistry and Research Development Cell at Parul University, Vadodara, India, and a CSIR-Research Associate with expertise spanning soft functional supramolecular materials, green organic synthesis, and photoredox chemistry. His research centers on designing calixarene-based architectures, liquid-crystal semiconductors, and environmentally responsible organic transformations using heterogeneous catalysts. He has made significant contributions to sustainable chemistry through the development of visible light-mediated methodologies and the innovative application of deep eutectic solvents to achieve scalable, eco-friendly catalytic processes adaptable from milligram to kilogram levels. Dr. Sharma earned his Ph.D. in Chemistry from Gujarat University, where he investigated mesogenic properties in novel homologous series and their structural, physical, chemical, and biological significance. His academic journey also includes an M.Sc. in Organic Chemistry and a B.Sc. in Chemistry from Gujarat University-affiliated institutions. A productive researcher, he has authored 114 scientific documents that have collectively received 1,248 citations from 671 citing sources, reflecting a strong scholarly impact supported by an h-index of 19. Dr. Sharma continues to advance sustainable molecular design and green chemical technologies through interdisciplinary and application-driven research.

Profile: Scopus

Featured Publications

  • Author, A., Author, B., Author, C., & Author, D. (2025). Design, synthesis, and phase behavior of furfural based calamitic liquid crystal with chalcone group: Impact of terminal groups and DFT study. Journal of Molecular Structure.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Indolo-[2,3-b]quinoxaline: A core for the stabilization of room temperature liquid crystalline self-assembly, aggregation-induced emission, and bioimaging applications. ACS Applied Bio Materials.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Phenoxazine-based ambipolar luminescent room-temperature liquid crystals capable of being used in bioimaging applications. Journal of Materials Chemistry B.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Resorcin[4]arene: Alkyl chain modulation for liquid crystals and photophysical properties. Materials Today Chemistry.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Oxacalix[4]arene functionalized macrocycle with columnar liquid crystal phase and self-assembly tuned by reversible photoisomerization process. Journal of Molecular Structure.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Microcrystalline cellulose and cellulose nanocrystals: Ecofriendly and sustainable support materials in heterogeneous nanocatalysis for green organic transformations. [Journal name not provided].

  • Author, A., Author, B., Author, C., & Author, D. (2025). Application of Fe3O4@MCC nanoparticles as a heterogeneous catalyst for sustainable multicomponent synthesis of 2,3′-Biindoles. ChemCatChem.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Biosensors used for minimally invasive drug delivery monitoring. In [Book title not provided] (pp. xx–xx).

  • Author, A., Author, B., Author, C., & Author, D. (2025). Synthesis and characterization of nonlinear coumarin-functionalized liquid crystals incorporating chalcone and ester linkages. Molecular Crystals and Liquid Crystals.

  • Author, A., Author, B., Author, C., & Author, D. (2025). Synthesis and characterization of calamitic liquid crystals based on benzothiazole-substituted aroylhydrazone: Effect of terminal groups on phase behavior. Molecular Crystals and Liquid Crystals.

Gokhan Uyanık | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Gokhan Uyanık | Neuropharmacology | Best Researcher Award

Assist. Prof. Dr. Gokhan Uyanık | Hatay Mustafa Kemal University | Turkey

Assistant Professor Gokhan Uyanık is a faculty member in the Department of Obstetrics and Gynecology at the Faculty of Veterinary Medicine, Hatay Mustafa Kemal University, Turkey. His academic expertise lies in veterinary obstetrics and gynecology, with a particular focus on reproductive physiology and fertility enhancement in small ruminants. His doctoral research explored the effects of GnRH and TAK-683 administration on fertility following estrus synchronization during the anestrus period in ewes, contributing to advancements in reproductive management and animal breeding efficiency. He has actively engaged in undergraduate teaching, guiding clinical applications and practical veterinary training in obstetrics and gynecology. Dr. Uyanık has authored 5 scientific documents that have received 7 citations, reflecting his growing contribution to the veterinary reproductive science community. His h-index stands at 2, indicating a developing yet impactful research trajectory. Through his integration of clinical practice, teaching, and experimental research, he aims to enhance understanding and management of reproductive disorders in animals. His academic presence is supported by international researcher identifiers, including ORCID and Scopus, ensuring global visibility and collaboration within the scientific community.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Gozer, A., Uyanik, G., Keceli, H. H., Kaya, U., and Ozkan, H. (2025). Upregulation of miR-125b and miR-23b in plasma might be related with the early pregnancy in Awassi ewes. Small Ruminant Research, 107579.

Cerci, E., Saribay, M. K., and Uyanik, G. (2025). Ineklerde Vitamin A, D ve E’nin fertilite uzerine etkisi: Derleme. Bahri Dagdas Hayvancilik Arastirma Dergisi, 14(1), 28–43.

Gozer, A., Bahan, O., Uyanik, G., Kaya, U., Arslanhan, E., Kucukkara, B., and Tatar, G. (2025). The effects of prepartum vitamin E/selenium and melatonin treatment on uterine involution of Awassi sheep in Hatay. Kocatepe Veterinary Journal, 18(2), 104–111.

Uyanik, G. and Gozer, A. (2025). Effect of different doses of equine chorionic gonadotrophin on the pregnancy rates in the Awassi ewes in out-of-breeding season. 9th International Congress on Veterinary and Animal Sciences, 105–106.

Uyanik, G. (2024). Koyunlarda anostrus doneminde ostrus senkronizasyonu sonrasi GnRH veya TAK-683 uygulamasinin fertiliteye etkisi. Master’s thesis, Erciyes University, Institute of Health Sciences, Department of Veterinary Obstetrics and Gynecology.

Kose, S. I., Erturk, A., Uyanik, G., and Ozturk, A. S. (2024). Evaluation of relationship between C-reactive protein, leukocyte count and platelet indices in dogs with leukocytosis. Kocatepe Veterinary Journal, 17(3), 270–279.

Kose, S. I., Ozturk, A. S., Uyanik, G., Erturk, A., and Durgut, R. (2023). What is the latest status of cats’ health in Hatay (Turkey) province following the SARS-CoV-2 pandemic? Kocatepe Veterinary Journal, 16(3), 450–458.

Uyanik, G., Kose, S. I., and Ozturk, A. S. (2021). Can rheumatoid factor use in the diagnosis of osteomalacia in dogs: A case report.

Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Assoc. Prof. Dr. Carmen Berenguer | Universitat de Valencia | Spain

Dr. Carmen Berenguer is an Associate Professor in the Department of Developmental and Educational Psychology at the University of Valencia. She holds a degree in Psychology, a Master’s in Cognitive Neuroscience and Special Educational Needs, and a Ph.D. in Psychology with the distinction of Cum Laude and International Doctorate from the same university. Her research has consistently focused on neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD), exploring cognitive, social, communication, and learning dimensions. In recent years, she has extended her work to examine comorbid conditions such as sleep difficulties and to design psychosocial intervention programs for families of children with ASD and ADHD. Dr. Berenguer has completed or participated in nine research projects and authored 20 books. She holds two patents related to psychosocial programs and augmented reality applications for educational and therapeutic purposes. With 54 published documents, her work has been cited in 994 scientific papers, accumulating a total of 1,077 citations and achieving an h-index of 17, reflecting her significant impact in developmental psychology and neurodevelopmental research.

Profiles: Scopus | orcid | Google Scholar

Featured Publications

(2025). Characteristics, motivations and attitudes of students using ChatGPT and other language model-based chatbots in higher education. Education and Information Technologies.

(2025). Parenting stress in autistic and ADHD children: Implications of social support and child characteristics. Journal of Autism and Developmental Disorders.

(2025). Sleep disturbances in autistic children and adolescents: A systematic review and meta-analysis of randomized controlled trials.

(2025). Augmented reality and learning-cognitive outcomes in autism spectrum disorder: A systematic review.

(2025). Occupational stress, burnout, and job satisfaction amongst Spanish speech-language pathologists. International Journal of Speech Language Pathology.

William Blumentals | Clinical Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Dr. William Blumentals | Clinical Neuroscience | Excellence in Research Award

Dr. William Blumentals | Sanofi | United States

Dr. William A. Blumentals is an accomplished epidemiologist and pharmaceutical executive recognized for his leadership in pharmacoepidemiology, real-world evidence generation, and global health outcomes research. He serves as Associate Vice President and Head of Specialty Care Pharmacoepidemiology at Sanofi in Cambridge, Massachusetts, where he oversees a multinational team of epidemiologists across the United States and Europe, driving innovation in inflammation, immunology, oncology, and rare disease research. With a Ph.D. in Epidemiology from the University of South Florida, along with advanced degrees in Statistics, Epidemiology, and Biology, Dr. Blumentals has held senior positions at leading organizations including Shire Pharmaceuticals, Shionogi Inc., and Hoffmann-La Roche. His expertise spans strategic development of large-scale observational studies, organizational leadership, and cross-functional collaboration to optimize evidence-based decision-making in healthcare. As a thought leader in real-world evidence and outcomes research, he has contributed significantly to advancing global epidemiological practices. Dr. Blumentals has authored 36 scientific documents, accumulated 1,594 citations from 1,463 documents, and holds an h-index of 23, reflecting his strong scientific influence and impact in epidemiology and pharmaceutical research.

Profile: Scopus

Featured Publications

Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. (2025). Multiple Sclerosis and Related Disorders.


Cytokine release syndrome risk model with T-cell engaging therapies. (2025). Cytotherapy.


Evaluating the accuracy of responses by large language models for information on disease epidemiology. (2025). Pharmacoepidemiology and Drug Safety.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Calixto Machado | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Calixto Machado | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Calixto Machado | Institute of Neurology and Neurosurgery | Cuba

Calixto Machado is a Full Professor and Senior Researcher in Neurology and Clinical Neurophysiology at the Institute of Neurology and Neurosurgery in Havana, Cuba, and a Corresponding Fellow of the American Academy of Neurology. He completed his medical degree, followed by specialist training in neurology and clinical neurophysiology, and then earned his PhD. Over four decades he has led pioneering research on disorders of consciousness, brain death, stroke, autism, autonomic nervous system disorders and the neurological sequelae of SARS-CoV-2. He has published nearly 700 peer-reviewed journal articles, book chapters and authored seven books; his work is recognised internationally through numerous symposia and awards. His Google Scholar profile lists an h-index of 37, and over 24 000 citations across his published documents.

Profile: Google Scholar

Featured Publications:

Machado, C. (2025, September 9). Jahi McMath case: A comprehensive and updated narrative. World Journal of Critical Care Medicine, 14(3), 107513.

Machado, C. (2022). The Jahi McMath case: First detailed study of her brain. Neurology India, 70(5), 22–35.

Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., Kelly, J. P., & others. (2002). The minimally conscious state: Definition and diagnostic criteria. Neurology, 58(3), 349–353.

Sloan, M. A., Alexandrov, A. V., Tegeler, C. H., Spencer, M. P., Caplan, L. R., & others. (2004). Assessment: Transcranial Doppler ultrasonography report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 62(9), 1468–1481.

Machado, C. (2002). Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology.

Machado, C. (2007). Cerebral response to patient’s own name in the vegetative and minimally conscious states. Neurology, 69(7), 708.

Machado, C., Korein, J., Ferrer, Y., Portela, L., & others. (2007). The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics, 33, 197–200.

Machado, C. (2007). The concept of brain death did not evolve to benefit organ transplants. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2007). Brain death: A reappraisal. Springer Science & Business Media.

Machado, C. (2007). The first organ transplant from a brain-dead donor. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2010). Diagnosis of brain death. Neurology International, 2(1), e2.

Graf, W. D., Miller, G., Epstein, L. G., & Rapin, I. (2017). The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology, 88(14), 1371–1380.

Machado, C., Korein, J., Aubert, E., Bosch, J., Alvarez, M. A., Rodríguez, R., & others. (2007). Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience, 38(3), 124–126.

Lewis, A., Bernat, J. L., Blosser, S., Bonnie, R. J., Epstein, L. G., Hutchins, J., & others. (2018). An interdisciplinary response to contemporary concerns about brain death determination. Neurology, 90(9), 423–426.*

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Maria -Camelia Stancioaica | Clinical Neuroscience |

Published on by Neuroscientists

Ms. Maria -Camelia Stancioaica | Clinical Neuroscience | Best Researcher Award

Ms. Maria -Camelia Stancioaica | Fundeni Clinical Hospital | Romania

Dr. Maria Camelia Stăncioaica is a dedicated Romanian hematologist affiliated with the Fundeni Clinical Institute in Bucharest, where she serves as the Acute Leukemia Program Coordinator. She holds an M.D. in Clinical Hematology and is currently pursuing her Ph.D. at the Carol Davila University of Medicine. Her professional development includes international experience through observership at Johns Hopkins Hospital in the USA and an internship at Pitié–Salpêtrière Hospital in France. Dr. Stăncioaica has contributed to advancing hematologic research through publications addressing acute leukemia, fungal infections in immunocompromised patients, and targeted therapies in acute myeloid leukemia. Her notable works include studies on FLT3 inhibitors, differentiation syndrome in pregnancy, and invasive fusariosis outbreaks. Actively engaged in global scientific dialogue, she has been a speaker and session chair at prominent hematology conferences across Europe. She also participates in several clinical trials as both principal and subinvestigator, focusing on novel therapeutic strategies in leukemia management. Dr. Stăncioaica’s research achievements are reflected in her 21 citations, 2 h-index, and 1 i10-index, underscoring her growing influence in clinical hematology. She is a member of the European Hematology Association and the Romanian Society of Hematology, contributing to both national and international medical communities.

Profile: Google Scholar

Featured Publications

1. Ghiaur, A., Doran, C., Gaman, M. A., Ionescu, B., Tatic, A., Cirstea, M., … Stancioaica, M. C. (2024). Acute promyelocytic leukemia: Review of complications related to all-trans retinoic acid and arsenic trioxide therapy. Cancers, 16(6), 1160.

2. Mohorea‐Neata, A. L., Ghita, M. C., Moroti, R., Ghiaur, A., Ionescu, B., Tatic, A., … Stancioaica, M. C. (2023). Invasive fusariosis in acute leukaemia patients—An outbreak in the haematology ward. Mycoses, 66(8), 705–710.

3. Droc, G., Stancioaica, M. C., Soare, C. G., Stefan, M. G., Ingustu, D., Martac, C., … Ghiaur, A. (2023). Acute promyelocytic leukemia and severe differentiation syndrome in pregnancy—A management challenge. Life, 13(5), 1141.

4. Coriu, D., & Stancioaica, M. C. (2023). Moving low-risk myelodysplastic syndromes from humans to mice: Is it truly that simple? Haematologica, 109(1), 8.

5. Stancioaica, M. C., Coriu, D., & Ghiaur, G. (2025). FLT3: A 35-year voyage from discovery to the next generation of targeted therapy in AML. Cancers.

Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Published on by Neuroscientists

Assist. Prof. Dr. Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Assist. Prof. Dr. Chun-An Cheng | Tri-Service General Hospital | Taiwan

Assistant Professor Dr. Chun-An Cheng is a distinguished researcher affiliated with the Tri-Service General Hospital, Taiwan, known for his significant contributions to medical and clinical research. He has authored 73 scholarly documents, which have collectively garnered 658 citations across 620 publications, reflecting the wide impact and recognition of his scientific work. With an h-index of 14, Dr. Cheng has demonstrated consistent research productivity and influence within his field. His research encompasses multidisciplinary areas in clinical medicine, focusing on advancing diagnostic methodologies, therapeutic innovations, and patient-centered healthcare strategies. Through his collaborations and publications, Dr. Cheng has contributed to improving the understanding of complex medical conditions and enhancing evidence-based clinical practices. His dedication to translational research bridges the gap between laboratory findings and clinical applications, reinforcing his role as a key figure in the Taiwanese medical research community. Dr. Cheng continues to drive impactful studies that promote innovation, patient safety, and improved health outcomes, positioning him as a leading voice in contemporary clinical science.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • (2025). Effects of exposure to air pollution and cold weather on acute myocardial infarction mortality. Atmosphere.

  • (2025). The risk of ischemic stroke in patients with chronic obstructive pulmonary disease and atrial fibrillation. Life.

  •  (2024). Increased risk of psychiatric disorder in patients with hearing loss: A nationwide population-based cohort study. Journal of Translational Medicine.

  • (2024). Diabetes mellitus and gynecological and inflammation disorders increased the risk of pregnancy loss in a population study. Life.

  • (2024). The influence of fine particulate matter and cold weather on emergency room interventions for childhood asthma. Life.

  • (2024). Impact of foodborne disease in Taiwan during the COVID-19 pandemic. Medicina (Lithuania).

  • (2024). Analyzing COVID-19 and air pollution effects on pediatric asthma emergency room visits in Taiwan. Toxics.

Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | University of Tokyo | Japan

Dr. Tatsuya Yamasoba is a Professor Emeritus at the University of Tokyo and Director of Tokyo Teishin Hospital, recognized internationally for his contributions to otology, neurotology, laryngology, and clinical neuroscience. He has published over 500 scientific papers in leading journals such as Science, Nature Chemistry, Nature Nanotechnology, Neuron, PNAS, and Neurology. His research focuses on regenerative medicine for sensorineural hearing loss, vestibular dysfunction, and dysphagia management in neurodegenerative diseases. With a citation index of over 24,150, an h-index of 75, and an i10-index of 353, his work has significantly advanced understanding and treatment of auditory and balance disorders. He has developed surgical techniques for severe hearing loss, pioneered galvanic vestibular stimulation therapy for disequilibrium, and improved aspiration prevention surgeries. Dr. Yamasoba has served as Editor-in-Chief of Auris Nasus Larynx and Associate Editor for ORL Journal and npj Aging and Mechanisms of Disease. He collaborates with leading research institutions including the University of Michigan and the University of California, Davis. His professional memberships include the International Federation of ORL Societies and the Asia Oceania Otorhinolaryngology and Head and Neck Society, reflecting his leadership and influence in advancing otolaryngology and auditory neuroscience globally.

Profile: Google Scholar

Featured Publications

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., et al. (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309(5733), 481–484.

Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., et al. (2015). Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC study. Allergy, 70(8), 995–1003.

Yamasoba, T., Lin, F. R., Someya, S., Kashio, A., Sakamoto, T., & Kondo, K. (2013). Current concepts in age-related hearing loss: Epidemiology and mechanistic pathways. Hearing Research, 303, 30–38.

Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., & Miller, J. M. (2007). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.

Umezawa, K., Yoshida, M., Kamiya, M., Yamasoba, T., & Urano, Y. (2017). Rational design of reversible fluorescent probes for live-cell imaging and quantification of fast glutathione dynamics. Nature Chemistry, 9(3), 279–286.

Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., et al. (2016). Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nature Nanotechnology, 11(6), 533–538.

Iwasaki, S., & Yamasoba, T. (2014). Dizziness and imbalance in the elderly: Age-related decline in the vestibular system. Aging and Disease, 6(1), 38–47.

Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., et al. (2009). Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences, 106(46), 19432–19437.